Medispektrum Plus, s.r.o.

Bratislava 85101

0 studies enrolling now · 2 studies all time

What they study most

Dyslipidemia, Type 2 Diabetes Mellitus, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes — Completed